Back
Dorman Products Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
52
DORM
Dorman Products
Last Price:
$126.44
Seasonality Move:
6.56%
Buy
58
ALNY
Alnylam Pharmaceuticals
Last Price:
$292.71
Seasonality Move:
22.81%
Buy
52
Dorman Products (DORM)
is a Buy
Is Dorman Products a Buy, Sell or Hold?
-
The current Dorman Products [DORM] share price is $126.43. The Score for DORM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
DORM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $292.58. The Score for ALNY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DORM Stock Price Chart
What is Dorman Products's stock price today?
-
The Dorman Products share price today is $126.43The current trend is moderately bullish and DORM is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $292.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
DORM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.72 | Buy |
Relative Strength Index (14 RSI): | 56.22 | Buy |
Chaikin Money Flow: | -94693 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.41 | Buy |
Relative Strength Index (14 RSI): | 65.15 | Buy |
Chaikin Money Flow: | -177421 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (243 - 280.14) | Buy |
Bollinger Bands (100): | (238.48 - 272.94) | Buy |
DORM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.88 | Sell |
20-day SMA: | 122.28 | Buy |
50-day SMA: | 120.56 | Buy |
200-day SMA: | 122.38 | Buy |
8-day EMA: | 128.24 | Sell |
20-day EMA: | 122.78 | Buy |
50-day EMA: | 100.37 | Buy |
200-day EMA: | 42.72 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 281.18 | Buy |
20-day SMA: | 268.14 | Buy |
50-day SMA: | 257.19 | Buy |
200-day SMA: | 260.9 | Buy |
8-day EMA: | 282.78 | Buy |
20-day EMA: | 270.74 | Buy |
50-day EMA: | 261.11 | Buy |
200-day EMA: | 248.51 | Buy |
Dorman Products Earnings Growth & DORM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.02 per share, an increase this year of $0.91 per share, and an increase next year of $0.67 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.03 per share, an increase next quarter of $1.64 per share, an increase this year of $1.16 per share, and an increase next year of $3.12 per share.
Dorman Products Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |